1. Patients with extra-adrenal malignancies and adrenal lesions have similar rates of subclinical hypercortisolism compared with patients with true adrenal incidentalomas
- Author
-
Kalliopi Pazaitou-Panayiotou, Anastasia Devlioti, Fani Apostolidou-Kiouti, Eirini Poimenidou, Maria Boudina, Grigorios Rallis, Achilleas Papanikolaou, Alexandra Chrisoulidou, and Pantelitsa Rakitzi
- Subjects
Adult ,Male ,medicine.medical_specialty ,Cortisol awakening response ,Hydrocortisone ,Endocrinology, Diabetes and Metabolism ,Adrenal Gland Diseases ,Adrenal Gland Neoplasms ,030209 endocrinology & metabolism ,030204 cardiovascular system & hematology ,Malignancy ,Gastroenterology ,Dexamethasone ,Body Mass Index ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Neoplasms ,medicine ,Humans ,Cushing Syndrome ,Glucocorticoids ,Subclinical infection ,Morning ,Aged ,business.industry ,Extra-Adrenal ,Cancer ,General Medicine ,Middle Aged ,medicine.disease ,Hypercortisolemia ,Dexamethasone suppression test ,Female ,business - Abstract
During follow-up in cancer patients, adrenal lesions are frequently found by computer tomography imaging. In these patients, the frequency of subclinical Cushing’s syndrome (SCS) has not been fully explored. The aim of the present study was to investigate the presence of SCS in cancer patients with adrenal lesions in comparison to patients with true adrenal incidentalomas. We studied 95 patients with adrenal lesions: 57 patients (group A, 20 males and 37 females) had a history of extra-adrenal malignancy and adrenal lesions were discovered during staging of the primary cancer, and 38 patients (group B, 6 males and 32 females) had adrenal incidentalomas. The two groups had similar BMI. All patients had unenhanced HU
- Published
- 2018